Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Kidney failure planning and conservative care

Renal · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull

Synopsis

Plan ahead with people approaching kidney failure, compare replacement therapies with comprehensive conservative management, and translate an informed preference into coordinated, symptom-focused care.

  • Begin kidney-failure education early enough for reflection, family involvement, transplant assessment and elective access creation; a crisis admission is a poor setting for first hearing the options.
  • Offer balanced information about transplantation, home or in-centre dialysis and comprehensive conservative management, including likely treatment burden, uncertainty and effects on everyday life.
  • NICE advises considering preparation for renal replacement therapy or conservative management at least one year before therapy is likely to be needed, allowing for individual progression and clinical judgement.
  • Start dialysis because symptoms, biochemical disturbance or uncontrollable fluid overload require it, or around an eGFR of 5 to 7 mL/min/1.73 m² when there are no symptoms; never use one higher eGFR threshold automatically.
  • Conservative management is active multidisciplinary kidney care without dialysis: it includes control of CKD complications, symptom treatment, psychological and social support, advance care planning and end-of-life care when appropriate.
  • Decision-making must be shared and revisited because frailty, cognition, transplant eligibility, home support, goals and the balance between benefit and burden can change.
  • Record the person's preferred modality, acceptable alternatives, escalation limits, resuscitation discussion where relevant and who should be contacted if deterioration occurs.
  • A decision not to dialyse does not mean withholding antibiotics, transfusion, diuresis, analgesia, nutrition support or hospital care unless these are also outside the person's agreed goals.
  • Pulmonary oedema, refractory hyperkalaemia, severe acidosis, uraemic pericarditis or encephalopathy still require urgent renal assessment even when a conservative pathway is being considered.

Key red flags

Severe breathlessness with hypoxaemia or pulmonary oedema needs same-day emergency assessment and may require urgent ultrafiltration or dialysis despite previous stable planning.

ECG-toxic hyperkalaemia, progressive weakness or a rapidly rising potassium requires immediate cardiac protection and a renal removal strategy.

New confusion, seizure, pericarditic pain, bleeding tendency or persistent vomiting can represent advanced uraemia and should trigger urgent renal review.

A statement requesting treatment withdrawal during untreated depression, delirium, coercion or uncontrolled symptoms requires prompt capacity, safeguarding and reversible-cause assessment.

Sudden loss of an agreed home-care package or carer exhaustion can make an otherwise sound plan unsafe and warrants urgent multidisciplinary coordination.

Investigation priorities

01
Serial renal profile and trajectoryFirst step

Estimate the pace of kidney failure and identify urgent biochemical indications for treatment.

02
Advance care planning reviewPreferred

Confirm capacity, understanding, proxy decision-makers, escalation preferences and preferred place of care.

Management branches

PREPAREProgressive advanced CKD

Risk and trajectory suggest kidney replacement therapy or conservative care may be needed within the planning horizon.

  1. Arrange multidisciplinary education using accessible language, interpreters and decision support, inviting family or carers if the person wishes.
  2. Compare transplantation, each dialysis setting and comprehensive conservative care using individual comorbidity, likely burden and personally meaningful outcomes.
  3. Assess transplant eligibility and living-donor possibilities while evaluating vascular access, abdominal suitability, home circumstances and support needs.
  4. Document a preferred pathway and contingency option, then review after clinical change rather than treating the first choice as irrevocable.

Key medicines

Loop diuretic for residual diuresisSelect and titrate an oral or parenteral renal regimen with specialist input according to urine output and congestion.Monitor postural symptoms, sodium, potassium, blood pressure and dehydration; anuria will not respond and subcutaneous administration is a specialist palliative intervention.
Renally appropriate opioidChoose the agent, route and low starting dose from the local renal palliative protocol, then titrate to response.Morphine and codeine metabolites accumulate in severe renal failure; sedation, myoclonus and respiratory depression require review, and conversion to alfentanil or another option needs specialist calculation.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG107 renal replacement and conservative managementNational recommendations on preparation, shared decisions, starting treatment and conservative care.
  • NICE NG203 chronic kidney disease recommendationsCurrent national CKD monitoring, referral and complication-management context.
  • Scottish Palliative Care Guidelines alfentanilNHS Scotland specialist prescribing context for severe kidney impairment.
  • Scottish Palliative Care Guidelines nausea and vomitingMechanism-based palliative assessment and antiemetic selection guidance.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom